Oral Solid Dosage (OSD) is the inspection and evaluation of the manufacturing and control processes used to manufacture solid oral dosage form pharmaceutical products.
Related Guidance Documents
Advanced Manufacturing (1)
Manufacturing Operations (2)
Microbiological & Viral Contamination Control (1)
Community Discussions
Community Discussions
May 02, 2024
May 01, 2024
Apr 30, 2024
Apr 30, 2024
Apr 26, 2024
Apr 25, 2024
Data Integrity
GAMP
Apr 25, 2024
Related Pharmaceutical Engineering Magazine Articles
ISPE Briefs: A Comprehensive Reference for Continuous Manufacturing of OSD
The pharmaceutical industry began applying the principles of continuous processing to the…
Artificial Intelligence Used to Optimize Fluid Bed Drying
This article shows how non-supervised artificial intelligence (AI) methods can strongly support…
Validation 4.0: Case Studies for Oral Solid Dose Manufacturing
Three case studies on Validation 4.0 demonstrate how quality by design (QbD) principles, when…
Regulatory Aspects of Global Acceptance of Continuous Manufacturing
Application of continuous manufacturing (CM) in the pharmaceutical industry is gaining momentum…
Material Properties Databases to Advance Pharmaceutical Processing
Pharmaceutical manufacturers rely heavily on powder processes, the majority of which are designed…
Concept and Discussion Papers
Process Validation Lifecycle for Packaging Oral Solid Dosage Forms
In August 2017, ISPE published the Discussion Paper “Overview of Packaging Validation for Drug…
Videos Related to Oral Solid Dosage
Training Courses Related To Oral Solid Dosage
GMP Sterile Pharmaceutical Manufacturing Facility Training Course
This course uses the second edition of the ISPE Baseline® Guide: Sterile Product Manufacturing Facilities and the FDA's Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing - Current Good Manufacturing Practice to provide an understanding of the key requirements and GMPs for sterile manufacturing facilities.
Concept and Discussion Papers
March / April 2024
Navigating the Asia Pacific Pharmaceutical Landscape for Global Impact Cover: The Asia Pacific…
Pharma 4.0 – Towards IT/OT Architectures for Prescriptive Maintenance
Introduction Faced with global competition and shrinking margins, (bio)pharmaceutical manufacturers…
Process Events for the Life Science Industry - Information Model Concept on OPC UA for Alarms and Audit Trails
Abstract Plug & play in general describes a piece of equipment that is ready to use upon connecting…